Effect of Cryopreserved Placental Explants on Female Reproductive System Under Normal and Pathological Conditions (Experimental study)
One of the most important tasks in current medicine is the preservation and restoration of fertility. The application of human placental derivatives (mesenchymal stromal cells, fetal membranes, extracts and explants), having a high proliferative potential and the affinity to female reproductive system, is a promising direction for treating female reproductive pathology. Here we determined the effect of cryopreserved placental explants on female reproductive system under normal condi-tions (fertility and estral cycle) and in pathology (infectious process, endocrinopathy, autoimmune pathology, trauma/ischemia). The cryopreserved placental explants were revealed to have a trophic effect on uterus and ovaries, they temporarily delayed ovulation and positively affected autoimmune, endocrine pathology and ischemia course. In addition, placental explants aggravated the infection course and increased the peritoneal adhesion formation.
Probl Cryobiol Cryomed 2017; 27(3): 250–265
Guan-Yu X., I-Hsuan L., Chun-Chun C. et al. Amniotic fluid stem cells prevent follicle atresia and rescue fertility of mice with premature ovarian failure induced by chemotherapy. PLoS One 2014; 9(9): e106538. CrossRef PubMed
Kulakov V.I., Adamyan L.V., Mynbayev O.A. Postoperative adhesions: etiology, pathogenesis, prevention. Moscow: Meditsina; 1998.
Lee J.M., Jung J., Lee H.J. et al. Comparison of immunomodulatory effects of placenta mesenchymal stem cells with bone marrow and adipose mesenchymal stem cells. Int Immunopharmacol 2012; 13(2): 219–224. CrossRef PubMed
Lee Y.K., Chung H.H., Kang S.B. et al. Efficacy and safety of human placenta extract in alleviating climacteric symptoms: prospective, randomized, double-blind, placebo-controlled trial. J Obstet Gynaecol Res 2009; 35(6): 1096–1101. CrossRef PubMed
Nasadyuk K.M. Cell technologies in reproductology, obstetrics and gynecology. Cell and Organ Transplantology 2013; 1(1): 61–65. CrossRef
Prokopyuk O.S., Prokopyuk V.Yu., Pasieshvili N.M. et al. Implantation of cryopreserved human placental fragments restores prooxidant-antioxidant balance in experimental animals of late ontogeny. Probl Cryobiol Cryomed 2017; 27(1): 61–70. CrossRef
Prokopyuk V.Yu., Prokopyuk O.S., Musatova I.B. et al. Safety of placental, umbilical cord and fetal membrane explants after cryopreservation. Cell and Organ Transplantology 2015; 3(1): 34–38. CrossRef
Ruiz A., Aguilar R., Tebar M. et al. RU486-treated rats show endocrine and morphological responses to therapies analogous to responses of women with polycystic ovary syndrome treated with similar therapies. Biol Reprod 1996; 55(6): 1284–1291. CrossRef PubMed
Schevchenko N.O., Somova K.V., Prokopyuk V.Yu. et al. Dynamics of activity and duration of functioning of cryopreserved cryoextract, placental cells and fragments in the organism of experimental animals. Morphologia 2016; 10(2): 93–98.
Stefanov O.V., editor. Preclinical trials of medicines [guidelines]. Kyiv: Avitsena; 2001.
Taskin O, Birincioglu M, Aydin A. et al. The effects of twisted ischaemic adnexa managed by detorsion on ovarian viability and histology: an ischaemia-reperfusion rodent model. Hum Reprod 1998; 13(10): 2823–2827. CrossRef PubMed
Trifonov V.Y., Prokopyuk V.Y., Zaychenko A.V. Cryopreserved cord blood serum for reproductive function restoration during antiphospholipid syndrome. Probl Cryobiol 2011: 21(1), 75–84.
Veenstra van Nieuwenhoven A.L., Heineman M.J., Faas M.M. The immunology of successful pregnancy. Hum Reprod 2003; 9(4): 347–57. CrossRef
Velayuthaprabhu S., Archunan G., Balakrishnan K. Placental thrombosis in experimental anticardiolipin antibodies-mediated intrauterine fetal death. Am J Reprod Immunol 2007; 57(4): 270–276. CrossRef PubMed
Zarinara A., Zeraati H., Kamali K. et al. Models predicting success of infertility treatment: a systematic review. J Reprod Infertil 2016; 17(2): 68–81. PubMed
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution 4.0 International License.
23, Pereyaslavskaya str., Kharkov, Ukraine
Tel. +38057 373 4143; Fax +38057 373 5952